Chat about Oxford Biomedica accounts information. See how Oxford Biomedica is performing financially.

Oxford Biomedica Accounts Summary


Date of Accounts 20222021202020192018
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement31-12-202231-12-202131-12-202031-12-201931-12-2018
Revenue139.99142.8087.7364.0666.78
Operating Profit / Loss-30.2220.77-5.69-14.4713.91
Net Interest-15.76-0.89-0.88-6.42-8.90
Pre Tax Profit-45.9819.88-6.57-20.895.01
Post Tax Profit-45.1619.01-6.25-16.077.54
Profit for the Period-45.1619.01-6.24-16.077.54
Equity Holders of Parent Company-39.1619.01-6.24-16.077.54
Minority Interests-6.00n/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)-41.29p22.77p-7.81p-22.10p11.57p
Earnings per Share (Diluted)-41.29p22.20p-7.81p-22.10p-10.89p
Earnings per Share (Adjusted)-41.29p22.77p-7.81p-22.10p11.57p
Continuing and Discontinued EPS     
Earnings per Share (Basic)-41.29p22.77p-7.81p-22.10p11.57p
Earnings per Share (Diluted)-41.29p22.20p-7.81p-22.10p-10.89p
Earnings per Share (Adjusted)-41.29p22.77p-7.81p-22.10p11.57p
      
Dividend per Sharen/apn/apn/apn/apn/ap
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31-12-202231-12-202131-12-202031-12-201931-12-2018
Non-Current Assets     
Intangible Assets105.890.050.070.100.12
Property, Plant and Equipment133.7869.7372.3061.9331.79
Investmentsn/an/an/an/a10.97
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/a-0.01
Other Non-Current Assets5.013.613.613.964.00
Total Non-Current Assets244.6873.3975.9865.9946.87
      
Current Assets     
Inventories12.629.526.912.584.25
Trade and Other Receivables61.5744.7553.9330.0526.59
Cash at Bank and in Hand141.28108.9446.7416.2432.24
Current Asset Investmentsn/an/an/an/an/a
Other Current Assets0.020.630.378.072.45
Total Current Assets215.50163.84107.9556.9465.53
      
Other Assetsn/an/an/an/an/a
Total Assets460.18237.23183.93122.93112.40
      
Current Liabilities     
Borrowings3.300.854.470.48n/a
Other Current Liabilities56.3732.4547.9828.4628.51
Total Current Liabilities59.6633.3152.4528.9428.51
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings110.998.499.377.9141.15
Provisions14.016.245.845.451.57
Other Non-Current Liabilities39.331.853.525.006.43
Total Non-Current Liabilities164.3216.5818.7318.3649.15
      
Net Assets236.19187.34112.7575.6334.74
      
Capital and Reserves     
Share Capital48.1343.0941.1638.4233.03
Share Premium Account379.95307.77258.02222.62172.07
Other Reserves-24.892.292.292.293.51
Retained Earnings-198.54-165.81-188.72-187.70-173.88
Shareholders Funds204.65187.34112.7575.6334.74
      
Minority Interests / Other Equity31.54n/an/an/an/a
Total Equity236.19187.34112.7575.6334.74
      
 31-12-202231-12-202131-12-202031-12-201931-12-2018
Operating Margin-21.59%14.54%-6.49%-22.59%20.83%
Return on Capital Employed-11.69%10.24%-4.30%-16.19%17.99%
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/a54.00n/an/a61.10
PEGn/an/an/an/an/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share135.10p194.18p116.82p78.31p35.90p